Oral Disposition Index Predicts the Development of Future Diabetes Above and Beyond Fasting and 2-h Glucose Levels
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: We sought to determine whether an oral disposition index (DI(O)) predicts the development of diabetes over a 10-year period. First, we assessed the validity of the DI(O) by demonstrating that a hyperbolic relationship exists between oral indexes of insulin sensitivity and beta-cell function. RESEARCH DESIGN AND METHODS: A total of 613 Japanese-American subjects (322 men and 291 women) underwent a 75-g oral glucose tolerance test (OGTT) at baseline, 5 years, and 10 years. Insulin sensitivity was estimated as 1/fasting insulin or homeostasis model assessment of insulin sensitivity (HOMA-S). Insulin response was estimated as the change in insulin divided by change in glucose from 0 to 30 min (DeltaI(0-30)/DeltaG(0-30)). RESULTS: DeltaI(0-30)/DeltaG(0-30) demonstrated a curvilinear relationship with 1/fasting insulin and HOMA-S with a left and downward shift as glucose tolerance deteriorated. The confidence limits for the slope of the log(e)-transformed estimates included -1 for DeltaI(0-30)/DeltaG(0-30) versus 1/fasting insulin for all glucose tolerance groups, consistent with a hyperbolic relationship. When HOMA-S was used as the insulin sensitivity measure, the confidence limits for the slope included -1 only for subjects with normal glucose tolerance (NGT) or impaired fasting glucose (IFG)/impaired glucose tolerance (IGT) but not diabetes. On the basis of this hyperbolic relationship, the product of DeltaI(0-30)/DeltaG(0-30) and 1/fasting insulin was calculated (DI(O)) and decreased from NGT to IFG/IGT to diabetes (P < 0.001). Among nondiabetic subjects at baseline, baseline DI(O) predicted cumulative diabetes at 10 years (P < 0.001) independent of age, sex, BMI, family history of diabetes, and baseline fasting and 2-h glucose concentrations. CONCLUSIONS: The DI(O) provides a measure of beta-cell function adjusted for insulin sensitivity and is predictive of development of diabetes over 10 years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 The computed slopes (——) and 95% CIs for the slopes (– – –) for ln(ΔI0–30/ΔG0–30) versus ln(1/fasting insulin) are plotted for subjects with NGT (slope −0.87 [95% CI −1.13 to −0.61]) (A), IGM (−0.84 [−1.05 to −0.63]) (B), and diabetes (DM) (−0.76 [−1.16 to −0.35]) (C). D: The hyperbolic curves for NGT, IGM, and diabetes, assuming a slope of −1, are plotted for ΔI0–30/ΔG0–30 versus 1/fasting insulin.](https://figures.cochat.ai/paper-figures/d5959647a3dd4b95864a9b906f9e5ab4/oral-disposition-index-predicts-the-development-of-future-diabetes-above-and-figure-1.jpg)
![Figure 2 A: The DIO (ΔI0–30/ΔG0–30 × 1/fasting insulin) decreases from NGT to IGM to diabetes (DM) (median [interquartile range]). B: The logarithmic means for baseline ΔI0–30/ΔG0–30 and 1/fasting insulin values are plotted for subjects with NGT (▪ and □) and IGM (• and ○) as nonprogressors (▪ and •) and progressors (□ and ○) relative to the hyperbolic curves. Progressors had lower β-cell function at baseline. C: The number of subjects who developed diabetes over the 10-year follow-up period by quintiles of baseline DIO. D: ROC curves comparing ability of baseline ΔI0–30/ΔG0–30 (dotted line), 1/fasting insulin (dashed line), and DIO (solid line) to predict cumulative diabetes at 10 years.](https://figures.cochat.ai/paper-figures/739976092a5449f2822cbdd9e3aacbd4/oral-disposition-index-predicts-the-development-of-future-diabetes-above-and-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“whereas children and adults with a low disposition index are most likely to progress to type 2 diabetes (19,34–38).”
From Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal Glycemia and Childhood Glucose Metabolism (2019) · cites this paper as [38]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Follow-up report on the diagnosis of diabetes mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3160 · Cited by 3,784 · cited 1×
“Classification of glucose tolerance Using the 2003 American Diabetes Association criteria (18), subjects were categorized as having normal glucose tolerance (NGT) (fasting plasma glucose [FPG] 5.”
MethodKahn, S. E. (2003) · Diabetologia · doi:10.1007/s00125-002-1009-0 · Cited by 2,166 · cited 2×
“Abnormalities in -cell function are present in high-risk individuals long before they develop hyperglycemia (1).”
BackgroundSelf-citationCorrect Homeostasis Model Assessment (HOMA) Evaluation Uses the Computer Program
Levy, J. C., Matthews, D. R., & Hermans, M. P. (1998) · Diabetes Care · doi:10.2337/diacare.21.12.2191 · Cited by 2,013
Weyer, C., Bogardus, C., Mott, D. M., & Pratley, R. E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7231 · Cited by 1,940
Bergman, R. N., Phillips, L. S., & Cobelli, C. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110398 · Cited by 1,640 · cited 1×
“sensitivity and insulin responses (2,3),”
Statistical Methods in Medical Research
Armitage, P., Berry, G., & Matthews, J. N. S. (2002) · Wiley eBooks · doi:10.1002/9780470773666 · Cited by 1,630
Kahn, S. E., Prigeon, R. L., McCulloch, D. K., Boyko, E. J., Bergman, R. N., Schwartz, M. W., Neifing, J. L., Ward, W. K., Beard, J. C., & Palmer, J. P. (1993) · Diabetes · doi:10.2337/diab.42.11.1663 · Cited by 1,405 · cited 4×
“intravenous tests (3) as well as between”
BackgroundInfluentialSelf-citationBuchanan, T. A., Xiang, A. H., Peters, R. K., Kjos, S. L., Marroquin, A., Goico, J., Ochoa, C., Tan, S., Berkowitz, K., Hodis, H. N., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2796 · Cited by 1,339
TCF7L2 Polymorphisms and Progression to Diabetes in the Diabetes Prevention Program
Florez, J. C., Jablonski, K. A., Bayley, N., Pollin, T. I., de Bakker, P. I. W., Shuldiner, A. R., Knowler, W. C., Nathan, D. M., & Altshuler, D. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062418 · Cited by 839
Cited by
Items 101–200 of 569
van Poppel, M. N. M., Oostdam, N., Eekhoff, E. M. W., Wouters, M. G. A. J., van Mechelen, W., & Catalano, P. M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1570 · Cited by 65
Bacha, F., Pyle, L., Nadeau, K., Cuttler, L., Goland, R., Haymond, M., Levitsky, L., Lynch, J., Weinstock, R. S., White, N. H., et al. (2012) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2011.00841.x · Cited by 52
The disposition index: adjustment for peripheral vs. hepatic insulin sensitivity?
Færch, K., Brøns, C., Alibegovic, A. C., & Vaag, A. A. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2009.184028 · Cited by 55
Insulin Dynamics of Breast- or Formula-Fed Overweight and Obese Children
Manco, M., Alterio, A., Bugianesi, E., Ciampalini, P., Mariani, P., Finocchi, M., Agostoni, C. V., & Nobili, V. (2011) · Journal of the American College of Nutrition · doi:10.1080/07315724.2011.10719941 · Cited by 48
β-Cell Dysfunction Is Associated with Metabolic Syndrome Severity in Adults
Malin, S. K., Finnegan, S., Fealy, C. E., Filion, J., Rocco, M. B., & Kirwan, J. P. (2014) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2013.0083 · Cited by 54
den Biggelaar, L. J. C. J., Sep, S. J. S., Eussen, S. J. P. M., Mari, A., Ferrannini, E., van Greevenbroek, M. M. J., Kallen, C., Schalkwijk, C. G., Stehouwer, C. D. A., & Dagnelie, P. C. (2016) · Diabetologia · doi:10.1007/s00125-016-4165-3 · Cited by 51
“This is in line with some other studies [26, 27], but there are studies that have established a hyperbolic function between BCF and insulin sensitivity [26, 28].”
ResultTale of two Indians: Heterogeneity in type 2 diabetes pathophysiology
Staimez, L. R., Deepa, M., Ali, M. K., Mohan, V., Hanson, R. L., & Narayan, K. M. V. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3192 · Cited by 50
“Clamp‐derived measures of insulin secretion and insulin resistance are gold‐standard measures; however, OGTT‐derived measures are valid; highly predictive of type 2 diabetes after 10 years; consistent with biological constructs; simulate true physiologic metabolic responses after glucose ingestion (eg, incretins); and…”
BackgroundMethodMartínez‐Sánchez, F. D., Vargas-Abonce, V. P., Guerrero-Castillo, A. P., Santos-Villavicencio, M. D. L., Eseiza-Acevedo, J., Meza-Arana, C. E., Gulías-Herrero, A., & Gómez-Sámano, M. Á. (2020) · Primary care diabetes · doi:10.1016/j.pcd.2020.10.006 · Cited by 48
Florez, J. C., Jablonski, K. A., McAteer, J. B., Franks, P. W., Mason, C. C., Mather, K. J., Horton, E. S., Goldberg, R. B., Dabelea, D., Kahn, S. E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044424 · Cited by 51
Self-citationSjaarda, L. A., Michaliszyn, S. F., Lee, S., Tfayli, H. M., Bacha, F. F., Farchoukh, L. O., & Arslanian, S. A. (2012) · Diabetes Care · doi:10.2337/dc12-0747 · Cited by 50
“Numerous longitudinal studies in adults have demonstrated the predictive value of DI (including oral DI) for the future development of diabetes (27,29,32,33).”
BackgroundLyu, L., Yu, J., Liu, Y., He, S., Zhao, Y., Qi, M., Ping, F., Xu, L., Li, W., Zhang, H., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab703 · Cited by 52
Transcriptomics in type 2 diabetes: Bridging the gap between genotype and phenotype
Jenkinson, C. P., Göring, H. H. H., Arya, R., Blangero, J., Duggirala, R., & DeFronzo, R. A. (2015) · Genomics Data · doi:10.1016/j.gdata.2015.12.001 · Cited by 50
Arancio, W., Amato, M. C., Magliozzo, M., Pizzolanti, G., Vesco, R., & Giordano, C. S. D. S. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1428299 · Cited by 46
β-Cell Death in Diabetes: Past Discoveries, Present Understanding, and Potential Future Advances
Mukherjee, N., Lin, L., Contreras, C., & Templin, A. T. (2021) · Metabolites · doi:10.3390/metabo11110796 · Cited by 49
Oka, R., Yagi, K., Sakurai, M., Nakamura, K., Moriuchi, T., Miyamoto, S., Nohara, A., Kawashiri, M., Takeda, Y., & Yamagishi, M. (2011) · Endocrine Journal · doi:10.1507/endocrj.ej11-0157 · Cited by 45
The degree of urinary hypercortisolism is not correlated with the severity of cushing’s syndrome
Guarnotta, V., Amato, M. C., Pivonello, R., Arnaldi, G., Ciresi, A., Trementino, L., Citarrella, R., Iacuaniello, D., Michetti, G., Simeoli, C., et al. (2016) · Endocrine · doi:10.1007/s12020-016-0914-9 · Cited by 45
Yanagimoto, A., Matsui, Y., Yamaguchi, T. F., Hibi, M., Kobayashi, S., & Osaki, N. (2022) · Nutrients · doi:10.3390/nu14235063 · Cited by 45
Santos, J. L., Yévenes, I., Cataldo, L. R., Morales, M., Galgani, J. E., Arancibia, C., Vega, J. L., Olmos, P. R., Flores, M., Valderas, J. P., et al. (2015) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-015-0458-0 · Cited by 45
Borel, A., Nazare, J., Smith, J. D., Alméras, N., Tremblay, A., Bergeron, J., Poirier, P., & Després, J. (2011) · Metabolism · doi:10.1016/j.metabol.2011.06.024 · Cited by 47
Is an Oral Glucose Tolerance Test Still Valid for Diagnosing Diabetes Mellitus?
Kim, D., Kim, S.-D., Kim, S. K., Park, S., & Song, K. (2016) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2016.40.2.118 · Cited by 41
Langsford, D., & Dwyer, K. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i10.1132 · Cited by 44
Barchetta, I., Dule, S., Bertoccini, L., Cimini, F. A., Sentinelli, F., Bailetti, D., Marini, G., Barbonetti, A., Loche, S., Cossu, E., et al. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01612-6 · Cited by 41
Wen, Y., Chen, C., Kong, X., Xia, Z., Kong, W., Si, K., Han, P., Liu, W. V., & Li, X. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109860 · Cited by 41
Youth-onset Type 2 Diabetes: An Overview of Pathophysiology, Prognosis, Prevention and Management
Titmuss, A., Korula, S., Wicklow, B. A., & Nadeau, K. J. (2024) · Current Diabetes Reports · doi:10.1007/s11892-024-01546-2 · Cited by 47
“Cardiovascular disease appears to be the major contributor to increased mortality even at a young age [19], including 17 serious cardiovascular events by 15 years-post diagnosis (average age 29 years) in the TODAY study [19], and at a far greater rate than in T1D [84, 89].”
BackgroundPollin, T. I., Jablonski, K. A., McAteer, J. B., Saxena, R., Kathiresan, S., Kahn, S. E., Goldberg, R. B., Altshuler, D., & Florez, J. C. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2324 · Cited by 43
“The oral disposition index (DIo) was defined as [(insulin at 30 min) (insulin at 0 min)]/[(glucose at 30 min) (glucose at 0 min)] (1/fasting insulin) (23).”
MethodSelf-citationSumner, A. E., Duong, M. T., Bingham, B. A., Aldana, P. C., Ricks, M., Mabundo, L. S., Tulloch-Reid, M. K., Chung, S. T., & Sacks, D. B. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2016.261255 · Cited by 43
Glucoregulatory Physiology in Subjects with Low-Normal, High-Normal, or Impaired Fasting Glucose
Dagogo-Jack, S. E., Askari, H., & Tykodi, G. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1348 · Cited by 40
Effect of Phosphodiesterase Inhibition on Insulin Resistance in Obese Individuals
Ho, J. E., Arora, P., Walford, G. A., Ghorbani, A., Guanaga, D. P., Dhakal, B. P., Nathan, D. I., Buys, E. S., Florez, J. C., Newton‐Cheh, C., et al. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.001001 · Cited by 39
Amato, M. C., Guarnotta, V., Forti, D., Donatelli, M., Dolcimascolo, S., & Giordano, C. (2013) · Human Reproduction · doi:10.1093/humrep/det105 · Cited by 38
“Indeed, DIo, which expresses the ability of b-cells to adequately compensate IR through increased insulin secretion, has been shown to predict the development of diabetes in adults (Utzschneider et al., 2009).”
BackgroundMethodOuyang, C., Gan, Z., Zhen, J., Guan, Y., Xing, Z., & Zhou, P. (2021) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2021.3061114 · Cited by 42
Hivert, M.-F., Christophi, C. A., Franks, P. W., Jablonski, K. A., Ehrmann, D. A., Kahn, S. E., Horton, E. S., Pollin, T. I., Mather, K. J., Perreault, L., et al. (2016) · Diabetes · doi:10.2337/db15-0950 · Cited by 38
Self-citationKim, J. Y., Tfayli, H. M., Michaliszyn, S. F., Lee, S., & Arslanian, S. A. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.02.004 · Cited by 43
Rapid Deterioration of Insulin Secretion in Obese Adolescents Preceding the Onset of Type 2 Diabetes
Elder, D. A., Hornung, L. N., Herbers, P. M., Prigeon, R. L., Woo, J. G., & D’Alessio, D. A. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2014.11.029 · Cited by 44
Self-citationXiang, A. H., Trigo, E., Martinez, M., Katkhouda, N., Beale, E., Wang, X., Wu, J., Chow, T., Montgomery, C., Nayak, K. S., et al. (2018) · Diabetes Care · doi:10.2337/dc18-1662 · Cited by 37
Self-citationMalin, S. K., Kullman, E. L., Scelsi, A. R., Godin, J., Ross, A. B., & Kirwan, J. P. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201800967 · Cited by 42
Angiotensin II Causes β-Cell Dysfunction Through an ER Stress-Induced Proinflammatory Response
Chan, S. M. H., Lau, Y. S., Miller, A. A., Ku, J., Potocnik, S. J., Ye, J., Woodman, O. L., & Herbert, T. P. (2017) · Endocrinology · doi:10.1210/en.2016-1879 · Cited by 38
Maki, K. C., Palacios, O. M., Lindner, E., Nieman, K. M., Bell, M., & Sorce, J. (2017) · Journal of Nutrition · doi:10.3945/jn.117.248641 · Cited by 38
Methods for Measuring Risk for Type 2 Diabetes in Youth: the Oral Glucose Tolerance Test (OGTT)
Chen, M. E., Aguirre, R. S., & Hannon, T. S. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1023-3 · Cited by 42
Gujral, U. P., Narayan, K. M. V., Kandula, N. R., Liu, K., & Kanaya, A. M. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-001063 · Cited by 37
Singhal, N., Misra, A., Shah, P., Gulati, S., Bhatt, S., Sharma, S., & Pandey, R. M. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2010.0094 · Cited by 38
“25 Waist circumference, a surrogate marker of abdominal adiposity, has also been associated with insulin resistance and predicts the presence of cardio-vascular risk factors in children and adolescents, 2,9 independently of BMI.”
Pendharkar, S. A., Singh, R. G., Bharmal, S. H., Drury, M., & Petrov, M. S. (2020) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001145 · Cited by 37
BRIKER, S. M., ADUWO, J. Y., Mugeni, R., Horlyck-Romanovsky, M., DuBose, C. W., Mabundo, L. S., Hormenu, T., Chung, S. T., Ha, J., Sherman, A., et al. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00533 · Cited by 35
Evidence That Hypothalamic Gliosis Is Related to Impaired Glucose Homeostasis in Adults With Obesity
Rosenbaum, J. L., Melhorn, S. J., Schoen, S., Webb, M. F., Leon, M. R. B. D., Humphreys, M., Utzschneider, K. M., & Schur, E. A. (2021) · Diabetes Care · doi:10.2337/dc21-1535 · Cited by 39
Self-citationAmato, M. C., Magistro, A., Gambino, G., Vesco, R., & Giordano, C. S. D. S. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0600 · Cited by 35
Pitfalls of HbA1c in the Diagnosis of Diabetes
Bergman, M., Abdul‐Ghani, M. A., Neves, J. S., Monteiro, M. P., Medina, J. L., Dorcely, B., & Buysschaert, M. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa372 · Cited by 36
Reproducibility and discrimination of different indices of insulin sensitivity and insulin secretion
Hudak, S., Huber, P., Lamprinou, A., Fritsche, L., Stefan, N., Peter, A., Birkenfeld, A. L., Fritsche, A., Heni, M., & Wagner, R. J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0258476 · Cited by 34
Mitri, J., Nelson, J., Ruthazer, R., Garganta, C. L., Nathan, D. M., Hu, F. B., Dawson-Hughes, B. F., & Pittas, A. G. (2014) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2013.293 · Cited by 41
Gagnon, C., Brown, C., Couture, C., Kamga-Ngandé, C., Hivert, M., Baillargeon, J., Carpentier, A. C., & Langlois, M. (2011) · Diabetes & Metabolism · doi:10.1016/j.diabet.2011.01.003 · Cited by 42
Feferman, L., Bhattacharyya, S., Oates, E., Haggerty, N., Wang, T., Varady, K. A., & Tobacman, J. K. (2020) · Journal of Diabetes Research · doi:10.1155/2020/8267980 · Cited by 34
Johansen, M. Y., Karstoft, K., MacDonald, C., Hansen, K. B., Ellingsgaard, H., Hartmann, B., Albrechtsen, N. J. W., Vaag, A. A., Holst, J. J., Pedersen, B. K., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05249-7 · Cited by 36
Ishimwe, M. C. S., Wentzel, A., SHOUP, E. M., OSEI-TUTU, N. H., Hormenu, T., Patterson, A. C., Bagheri, H., DuBose, C. W., Mabundo, L. S., Ha, J., et al. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002447 · Cited by 35
Utzschneider, K. M., Largajolli, A., Bertoldo, A., Marcovina, S., Nelson, J. E., Yeh, M. M., Kowdley, K. V., & Kahn, S. E. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.11.007 · Cited by 36
“The oral disposition index (ΔI/ΔG × 1/fasting insulin) was calculated as a measure of β-cell function (Utzschneider et al., 2009).”
MethodSelf-citationHannon, T. S., Rofey, D. L., Lee, S., & Arslanian, S. A. (2013) · Pediatric Diabetes · doi:10.1111/pedi.12035 · Cited by 29
Mackenzie, R., & Watt, P. (2016) · Journal of Diabetes Research · doi:10.1155/2016/6934937 · Cited by 37
Glucose Effectiveness in Obese Children: Relation to Degree of Obesity and Dysglycemia
Weiss, R., Magge, S. N., Santoro, N., Giannini, C., Boston, R. C., Holder, T. A., Shaw, M. M., Duran, E. J., Hershkop, K. J., & Caprio, S. (2015) · Diabetes Care · doi:10.2337/dc14-2183 · Cited by 33
Perugini, R. A., & Malkani, S. (2011) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283446c1f · Cited by 31
Mesquita, L. D. A., Antoniolli, L. P., Cittolin‐Santos, G. F., & Gerchman, F. (2018) · BMC Endocrine Disorders · doi:10.1186/s12902-018-0286-7 · Cited by 32
Gujral, U. P., Prabhakaran, D., Pradeepa, R., Kandula, N. R., Kondal, D., Deepa, M., Zakai, N. A., Anjana, R. M., Rautela, G., Mohan, V., et al. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.05.026 · Cited by 29
Diabetes detection in women with gestational diabetes and polycystic ovarian syndrome
Hanna, F., Wu, P., Heald, A. H., & Fryer, A. A. (2023) · BMJ · doi:10.1136/bmj-2022-071675 · Cited by 35
One-hour glucose is an earlier marker of dysglycemia than two-hour glucose
Ha, J., Chung, S. T., Bogardus, C., Jagannathan, R., Bergman, M., & Sherman, A. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110839 · Cited by 33
Relationship of betatrophin with youth onset type 2 diabetes among Asian Indians
Gokulakrishnan, K., Manokaran, K., Pandey, G. K., Amutha, A., Ranjani, H., Anjana, R. M., & Mohan, V. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.04.028 · Cited by 33
Naufahu, J., Elliott, B., Markiv, A., Dunning-Foreman, P., McGrady, M., Howard, D., Watt, P., & Mackenzie, R. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02019 · Cited by 31
“Plasma insulin, endogenous glucose concentrations, and [6,6(2)H2]glucose-enriched values were used to model the metabolic indices: insulin sensitivity (SI (2)*), glucose effectiveness (SG (2)*), and hepatic glucose production (HGP) as described previously (29, 30) (SAAMII Institute, Seattle, WA) SI (2)* explains the e…”
MethodEffect of low- and high-glycemic load on circulating incretins in a randomized clinical trial
Runchey, S. S., Valsta, L. M., Schwarz, Y., Wang, C., Song, X., Lampe, J. W., & Neuhouser, M. L. (2013) · Metabolism · doi:10.1016/j.metabol.2012.07.006 · Cited by 30
Insulin resistance in type 2 diabetic youth
Mizokami‐Stout, K., Cree‐Green, M., & Nadeau, K. J. (2012) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283557cd5 · Cited by 35
Measuring β-Cell Function Relative to Insulin Sensitivity in Youth
Sjaarda, L. A., Lee, S., Tfayli, H. M., Bacha, F. F., Bertolet, M. H., & Arslanian, S. A. (2012) · Diabetes Care · doi:10.2337/dc12-1508 · Cited by 37
“Statistical analyses To confirm a hyperbolic relationship between hyperglycemic clamp-measured insulin sensitivity and first-phase insulin, we used perpendicular least squares properly weighted linear regression of log-transformed variables in R (R Foundation for Statistical Computing, Vienna, Austria), an approach th…”
BackgroundMethodGuarnotta, V., Ciresi, A., Pillitteri, G., & Giordano, C. (2018) · Clinical Endocrinology · doi:10.1111/cen.13554 · Cited by 29
Goyal, A., Gupta, Y., Kalaivani, M., Sankar, M. J., Kachhawa, G., Bhatla, N., Gupta, N., & Tandon, N. (2019) · Diabetologia · doi:10.1007/s00125-019-4903-4 · Cited by 30
Lindåse, S. S., Nostell, K. E. A., Forslund, A. H., Bergsten, P., & Bröjer, J. T. (2023) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.16906 · Cited by 32
“17 Treatment with SGLT2 inhibitors in humans with T2DM leads to improved β -cell function.”
BackgroundOh, T. J., Min, S. H., Ahn, C. H., Kim, E. K., Kwak, S. H., Jung, H. S., Park, K. S., & Cho, Y. M. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.2.147 · Cited by 208
Santos, J. L., Krause, B. J., Cataldo, L. R., Vega, J. A., Salas‐Pérez, F., Mennickent, P., Gallegos, R., Milagro, F. I., Prieto-Hontoria, P. L., Riezu‐Boj, J. I., et al. (2020) · Nutrients · doi:10.3390/nu12092790 · Cited by 30
“In spite of the importance of genetics in T2D development, Genome-wide association studies (GWAS) have shown that only a relative low percentage of heritability of T2D can be explained by common gene variants [9], although recent sophisticated statistical analyses have provided evidence of a higher predictive ability…”
BackgroundInfluentialChan, C. L., Pyle, L. L., Vigers, T., Zeitler, P. S., & Nadeau, K. J. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab692 · Cited by 29
Lim, S. K., Han, K. A., Yu, J., Chamnan, P., Kim, E. S., Yoon, K., Kwon, S. H., Moon, M. K., Lee, K. W., Kim, D., et al. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12787 · Cited by 31
“The disposition index, which reflects β-cell function adjusted for insulin sensitivity, was calculated as IGI × Matsuda index.(15,16)”
MethodNowak, C., Salihović, S., Ganna, A., Brandmaier, S., Tukiainen, T., Broeckling, C. D., Magnusson, P. K. E., Prenni, J. E., Wang‐Sattler, R., Peters, A., et al. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006379 · Cited by 30
“Three outcomes were assessed: IR (clamp M/I), the insulinogenic index (log-IGI30) as a measure of glucose-stimulated insulin secretion [15] and the disposition index (log-DI) for β-cell responsiveness [16], all scaled to SD-units.”
BackgroundMethodGoedecke, J. H., George, C., Veras, K. M. D. A., Peer, N., Lombard, C. J., Victor, H., Steyn, K., & Levitt, N. S. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.11.005 · Cited by 30
Ciresi, A., Amato, M. C., & Giordano, C. S. D. S. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0184-4 · Cited by 32
Copenhaver, M. M., Yu, C. Y., Zhou, D., & Hoffman, R. P. (2019) · Pediatric Research · doi:10.1038/s41390-019-0534-1 · Cited by 28
“IS was calculated using the Matsuda index (IS= 10,000/√ [fasting glucose × fasting insulin] × [mean glucose ×mean insulin]), while insulin secretion (SEC) was calculated as the change in insulin divided by the change in glucose from 0 to 30min (SEC= ΔI0–30/ ΔG0–30).(22) Disposition index (DI) was calculated by multipl…”
MethodHeianza, Y., Arase, Y., Fujihara, K., Tsuji, H., Saito, K., Hsieh, S. D., Kodama, S., Shimano, H., Yamada, N., Hara, S., et al. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03667.x · Cited by 30
The Influence of Rare Genetic Variation in SLC30A8 on Diabetes Incidence and β-Cell Function
Billings, L. K., Jablonski, K. A., Ackerman, R. J., Taylor, A., Fanelli, R. R., McAteer, J. B., Guiducci, C., Delahanty, L. M., Dabelea, D., Kahn, S. E., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2378 · Cited by 27
Self-citationTsuchimochi, W., Ueno, H., Yamashita, E., Tsubouchi, C., Sakoda, H., Nakamura, S., & Nakazato, M. (2014) · Endocrine Journal · doi:10.1507/endocrj.ej14-0393 · Cited by 31
Hegelund-Myrbäck, T., Prothon, S., Edman, K., Leander, J., Hashemi, M., Dearman, M. S., Edenro, G., Svanberg, P., Andersson, E.-M., Almquist, J., et al. (2019) · The Lancet Rheumatology · doi:10.1016/s2665-9913(19)30103-1 · Cited by 32
Su, J., Chen, T., Xu, F., Wang, X., Chen, J., Wu, G., Jin, Y., & Wang, X. (2013) · Endocrine · doi:10.1007/s12020-013-0047-3 · Cited by 28
Soltero, E. G., Konopken, Y. P., Olson, M. L., Keller, C. S., Castro, F. G., Williams, A. N., Patrick, D. L., Ayers, S. L., Hu, P., Sandoval, M. T. P., et al. (2017) · BMC Public Health · doi:10.1186/s12889-017-4174-2 · Cited by 28
“thought to be an important physiologic measure for assessing changes in T2D risk over time [58, 59].”
BackgroundMalin, S. K., François, M. E., Eichner, N. Z. M., Gilbertson, N. M., Heiston, E. M., Fabris, C., & Breton, M. D. (2018) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00680.2018 · Cited by 27
“, disposition index) is considered a better predictor of future diabetes development than insulin sensitivity alone (1, 27, 38).”
BackgroundAndrogen deprivation in prostate cancer: benefits of home-based resistance training
Lam, T., Cheema, B. S., Hayden, A. J., Lord, S. R., Gurney, H., Gounden, S., Reddy, N., Shahidipour, H., Read, S. A., Stone, G., et al. (2020) · Sports Medicine - Open · doi:10.1186/s40798-020-00288-1 · Cited by 29
FKBP5 polymorphism is associated with insulin resistance in children and adolescents with obesity
Fichna, M., Krzyśko-Pieczka, I., Żurawek, M., Skowrońska, B., Januszkiewicz‐Lewandowska, D., & Fichna, P. (2016) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2016.11.007 · Cited by 27
Serum adiponectin and insulin secretion: A direct or inverse association?
Nakamura, A., Miyoshi, H., Ukawa, S., Nakamura, K., Nakagawa, T., Terauchi, Y., Tamakoshi, A., & Atsumi, T. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12821 · Cited by 26
Lee, M. J., Bae, J. H., Khang, A. R., Yi, D., Yun, M. S., & Kang, Y. H. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111640 · Cited by 27
Sex Differences in the Impact of Obstructive Sleep Apnea on Glucose Metabolism
Temple, K. A., Leproult, R., Morselli, L. L., Ehrmann, D. A., Cauter, E. V., & Mokhlesi, B. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00376 · Cited by 26
“5)], AUCinsulin/AUCglucose [AUCinsulin/glucose] (16), AUCISR, and insulinogenic index (IGI) (18).”
BackgroundMethodInfluentialvan den Burg, E. L., Schoonakker, M. P., van Peet, P. G., van den Akker-van Marle, E. M., Lamb, H. J., Longo, V. D., Numans, M. E., & Pijl, H. (2024) · Diabetologia · doi:10.1007/s00125-024-06137-0 · Cited by 25
“%) higher at the end of the study compared with baseline with no change in glucose-lowering medication disposition index (reflecting endogenous insulin secretion) [25–27].”
Short-Term Estrogen Withdrawal Increases Adiposity in Healthy Men
Chao, J., Rubinow, K. B., Kratz, M., Amory, J. K., Matsumoto, A. M., & Page, S. T. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1482 · Cited by 25
Garonzi, C., Maguolo, A., & Maffeis, C. (2022) · Hormone Research in Paediatrics · doi:10.1159/000528342 · Cited by 29
Yamaguchi, S., Irie, J., Mitsuishi, M., Uchino, Y., Nakaya, H., Takemura, R., Inagaki, E., Kosugi, S., Okano, H., Yasui, M., et al. (2024) · Endocrine Journal · doi:10.1507/endocrj.ej23-0431 · Cited by 27
Long-term recovery of β-cell function after partial pancreatectomy in humans
Menge, B. A., Breuer, T. G. K., Ritter, P. R., Uhl, W. H., Schmidt, W. E., & Meier, J. J. (2011) · Metabolism · doi:10.1016/j.metabol.2011.09.019 · Cited by 25
Merjaneh, L., He, Q. W., Long, Q., Phillips, L. S., & Stecenko, A. A. (2014) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2014.06.004 · Cited by 25
The disposition index: from individual to population approach
Denti, P., TOFFOLO, G. M., & Cobelli, C. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00139.2011 · Cited by 28
Exercise and Postprandial Glycemic Control in Type 2 Diabetes
Kearney, M. L., & Thyfault, J. P. (2016) · Current Diabetes Reviews · doi:10.2174/1573399811666150615112441 · Cited by 29
Insulin Resistance and β-Cell Dysfunction in Relation to Cardiometabolic Risk Patterns
Wang, T., Zhao, Z., Xu, Y., Qi, L., Xu, M., Lu, J., Li, M., Chen, Y., Dai, M., Zhao, W., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02584 · Cited by 25
The incretin effect in obese adolescents with and without type 2 diabetes: impaired or intact?
Aulinger, B. A., Vahl, T. P., Prigeon, R. L., D'Alessio, D. A., & Elder, D. A. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00496.2015 · Cited by 24
Self-citationAslamy, A., Wood, A. C., Jensen, E. T., Bertoni, A. G., Sheridan, P. A., Wong, K. E., Ramesh, G., Rotter, J. I., Chen, Y.-D. I., & Goodarzi, M. O. (2023) · Diabetes · doi:10.2337/db23-0401 · Cited by 28
Lee, Y., Lee, B., Chun, S., Cha, B. S., & Lee, H. C. (2011) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2011.02755.x · Cited by 24
Metadata
- Authors
- Utzschneider, K. M., Prigeon, R. L., Faulenbach, M. V., Tong, J., Carr, D. B., Boyko, E. J., Leonetti, D. L., McNeely, M. J., Fujimoto, W. Y., & Kahn, S. E.
- Affiliations
- University of Washington (US)
- University of Maryland, Baltimore (US)
- VA Puget Sound Health Care System (US)
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-02-01
- Volume
- 32
- Issue
- 2
- Pages
- 335-341
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2628704
- OpenAlex
- W2121328463
- Cited by
- 572
- References
- 27
- Citations by year
- 2026: 24 · 2025: 30 · 2024: 39 · 2023: 41 · 2022: 40 · 2021: 44 · 2020: 41 · 2019: 27 · 2018: 32 · 2017: 32 · 2016: 42 · 2015: 26 · 2014: 35 · 2013: 29 · 2012: 35
- FWCI
- 13.31
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- National Institutes of Health (P30 DK, HL‐49293, DK-31170)
- National Heart, Lung, and Blood Institute (R01HL049293)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-35816, P30-DK 17047, K24DK002654, DK 02654, R01DK031170, P30DK035816, P30DK017047)
- National Center for Research Resources (RR00037, M01RR000037)
- NIH Clinical Center (RR-00037)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R24HD042828)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- oral disposition index, diabetes prediction, beta-cell function, insulin sensitivity, hyperbolic relationship, oral glucose tolerance test, impaired fasting glucose, impaired glucose tolerance, HOMA-S, fasting insulin
- MeSH terms
- Blood Glucose, Diabetes Mellitus, Fasting, Feedback, Follow-Up Studies, Glucose Tolerance Test, Humans, Hyperglycemia, Insulin, Insulin Resistance, Predictive Value of Tests, Regression Analysis, Time Factors, Reproducibility of Results, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.